Insilico Medicine's generative AI platform was credited in a press release with 'discovering' a promising pulmonary-fibrosis drug, but the company's patent named five human inventors, including CEO Alex Zhavoronkov, and did not mention AI.
Sources
- MIT Technology Review (technologyreview.com)
- https://www.artiverse.ca/the-five-human-names-behind-an-ai-designed-drug/ (artiverse.ca)
- https://www.rajashreerajadhyax.com/post/when-ai-discovers-the-molecule-who-owns-the-invention (rajashreerajadhyax.com)
- https://bioethics.com/archives/103865 (bioethics.com)
- https://www.businessstory.org/2026/08/21/when-ai-designs-a-drug-who-gets-the-credit/ (businessstory.org)
More in Technology
- The article 'IC Failure Analysis: Magic, Mystery, and Science' was authored by Jerry M. Soden, Richard E. Anderson, and Chris L. Henderson.
- At the end of June 2023, the Netherlands announced restrictions on exporting deep ultraviolet (DUV) lithography machines to China.
- GOSAT is the name of a satellite used for greenhouse gas observation referenced in NIES's environmental communications.
- The monograph introduces an approach called the Atypical Signal Analysis and Processing (ASAP) schema for identifying atypical, out-of-the-ordinary behavior potentially related to terror activity.
- Nokia once manufactured rubber boots and toilet paper before becoming a mobile phone company.
- The CIA's Aquiline drone program was initially modeled on birds' flight characteristics but never became operational.